Ever Fortune.AI and Medexprim announce their strategic partnership dedicated to improving healthcare analytics and medical AI development. Ever Fortune.AI, a leading Taiwanese healthcare company, provides AI-powered solutions to hospitals, clinical research organizations, and pharmaceutical companies. It is an expert in… Read More
French version available here The University Hospital of Nîmes (CHU), a reference center in clinical research, has entrusted Medexprim with the construction of its IT environment dedicated to clinical research. With a capacity of 2,064 beds, places and stations, the… Read More
French version available here The College of Radiology Teachers of France (CERF) and Medexprim are proud to announce their three-year partnership to develop a tailor-made platform that will enable the CERF to structure the clinical research activity of the French… Read More
Paris, France, June 21st, 2021 Healcloud and Medexprim announce their strategic partnership dedicated to the analysis of clinical data for patient identification. Medexprim, the European expert in generating regulatory-grade datasets of aggregated images and clinical data, builds bridges between hospitals and pharmaceutical… Read More
Clinerion and Medexprim have concluded a three-year partnership dedicated to the merger of electronic health records and imaging data into a private clinical data cloud warehouse dedicated to research. Clinerion is the worldwide leader in medical data informatics, radically improving… Read More
Clermont-Ferrand University Hospital, SurgAR and Medexprim, are proud to announce their three-year strategic partnership to accelerate the development of SurgAR’s augmented reality software, dedicated to laparoscopic surgery (Read French Press Release here). The University Hospital Center (CHU) of Clermont-Ferrand, an… Read More
January 20, 2021, Paris, France The iHealth Group of Brazil and Medexprim partner to accelerate international clinical research in Brazil, and to boost the identification and the recruitment of patients into clinical trials. The iHealth Group, formed by a team… Read More
Medexprim is very proud to start its new collaboration in the H2020 EU CHAIMELEON project. CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management. By 2024, an… Read More
In this webinar Medexprim and Graticule convened a panel of experts that bridge across geographies and backgrounds to discuss solutions for sharing advanced Real World Data for COVID-19 research. The panel shares their expertise on data needs, data sharing, and… Read More
Romain Cazavan from Medexprim explains the nature of our partnership with Sophia Genetics and how we contribute to providing cleaned data to advance discoveries to fight cancer.
Boston, Mass – US-based Graticule and France based Medexprim announced a partnership today to provide a federated global network to power complex RWE (Real World Evidence) studies. The two companies have established complementary infrastructure and relationships with health systems and… Read More
Overland Park, KS – US-based Softek Illuminate and the entrepreneurial French firm Medexprim announced today they will be combining, distributing and supporting each other’s product offerings as a unified solution for hospital researchers interested in exploiting previously unstructured clinical and… Read More
Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data.
